Boeing (BA) Back In Focus As Avolon Order Tests An Overvalued Narrative
Boeing (BA) Back In Focus As Avolon Order Tests An Overvalued Narrative Simply Wall St
Covered in this story
Analyst targets on Boeing
- JPMorgan: $168 → $240 by Oct 2027 · Overweight via MarketBeat
- BNP Paribas Exane: $168 → $205 by Oct 2027 · Outperform via MarketBeat
- Wells Fargo: $168 → $210 by Oct 2027 · Overweight via MarketBeat
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Boeing →Dalsna Finance is currently tracking 50 stories mentioning Boeing, the earliest published 14 May 2026.
Summary aggregated from Simply Wall St's public RSS feed. The full reporting belongs to Simply Wall St — please read it on their site.